2024年肝纤维化非侵入性检测:有不同疾病的不同尺度吗?
Jimmy Che-To Lai1,2,3, Lilian Yan Liang1,2,3, Grace Lai-Hung Wong1,2,3
1Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR, China.
Gastroenterology report
|April 12, 2024
概括
非侵入性测试为肝纤维化评估提供了肝活检的实际替代方案. 本综述详细介绍了它们的诊断性能,局限性和在各种肝脏疾病中的应用.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 诊断成像 诊断成像 诊断成像
- 生物标志物 生物标志物
背景情况:
- 肝纤维化是肝硬化,门高血压和肝细胞癌的关键预测因素.
- 肝脏活检,黄金标准,是侵入性的,不适合连续监测.
- 准确评估肝纤维化对于患者的预后和管理至关重要.
研究的目的:
- 审查肝纤维化的非侵入性测试的诊断和预后性能.
- 讨论这些非侵入性评估工具的局限性和混因素.
- 评估各种肝脏疾病中非侵入性测试的有用性.
主要方法:
- 审查基于实验室的测试 (例行血液测试,专利参数).
- 分析基于成像的模式 (超声波,振动控制的短暂弹性体,磁共振弹性体).
- 考虑结合实验室和成像方法.
主要成果:
- 非侵入性测试为肝活检提供了切实可行的替代方案.
- 振动控制的瞬态弹性学得到了广泛的验证;磁共振弹性学显示出高精度.
- 非侵入性测试的性能和解释因不同的肝病和患者群体而异.
结论:
- 非侵入性测试对于评估肝纤维化很有价值,但它们的应用需要仔细考虑疾病背景.
- 为了准确的解释,必须承认局限性和混因素.
- 需要进一步的研究来优化临床实践中的非侵入性测试利用.
更多相关视频
相关概念视频
01:25Ultrasound II: Endoscopic Ultrasound and FibroScan
102
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
Endoscopic Ultrasound (EUS):
102
01:26Diseases of the Liver and Gallbladder
533
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
533